Current status and prospect of precision treatment for colorectal cancer
10.3760/cma.j.cn115610-20250509-00183
- VernacularTitle:结直肠癌精准治疗的现状与展望
- Author:
Hongwei YAO
1
;
Jiale GAO
1
;
Zhengyang YANG
1
;
Liting SUN
1
;
Pengyu WEI
1
;
Zhongtao ZHANG
1
Author Information
1. 首都医科大学附属北京友谊医院普通外科中心 国家消化系统疾病临床医学研究中心 消化健康全国重点实验室，北京 100050
- Publication Type:Journal Article
- Keywords:
Colorectal neoplasms;
Molecular classification;
Target detection;
Multidisci-plinary;
Precision;
Diagnosis and treatment
- From:
Chinese Journal of Digestive Surgery
2025;24(6):690-694
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, with continuous advancements in molecular biology and gene testing technologies, the diagnosis and treatment of colorectal cancer have been rapidly transitioning toward precision medicine. The application of molecular classification, target detection, and liquid biopsy technologies has driven ongoing updates to clinical guidelines. Multidisciplinary team colla-boration, innovations in precision surgical techniques, and the widespread adoption of neoadjuvant combination therapies have collectively promoted more individualized and scientific management of colorectal cancer. Looking ahead,the authors believe that as multi-omics biomarkers, organoid models, and artificial intelligence are increasingly integrated into clinical practice, precision diagnosis and treatment of colorectal cancer will deepen further, offering patients more efficient and personalized therapeutic options.
